Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Ward

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Blood|July 21, 2010
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cellsSumaiya Sharmeen, Marko Skrtic, Mahadeo A Sukhai, et al.
Radiology|February 22, 2023
Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SARScott B Reeder, Takeshi Yokoo, Manuela França, et al.
The Canadian Journal of Cardiology|August 27, 2018
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?Jean-Eric Tarride, F Russell Quinn, Gord Blackhouse, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 14, 2011
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE InitiativeSheldon W Tobe, James A Stone, Melissa Brouwers, et al.
The EMBO Journal|August 2, 2012
Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxisAlexander J Laarman, Gerdien Mijnheer, Joe M Mootz, et al.
Cell Communication and Signaling : CCS|March 13, 2026
Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradationGuancong Luo, Dexuan Li, Jun Peng, et al.
CJC Open|November 11, 2024
Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid GuidelineG B John Mancini, Glen J Pearson, Arden R Barry, et al.
The Canadian Journal of Cardiology|October 8, 2016
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultTodd J Anderson, Jean Grégoire, Glen J Pearson, et al.
The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
The Canadian Journal of Cardiology|March 5, 2014
Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia PanelTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Blood|July 21, 2010
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cellsSumaiya Sharmeen, Marko Skrtic, Mahadeo A Sukhai, et al.
Radiology|February 22, 2023
Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SARScott B Reeder, Takeshi Yokoo, Manuela França, et al.
The Canadian Journal of Cardiology|August 27, 2018
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?Jean-Eric Tarride, F Russell Quinn, Gord Blackhouse, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 14, 2011
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE InitiativeSheldon W Tobe, James A Stone, Melissa Brouwers, et al.
The EMBO Journal|August 2, 2012
Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxisAlexander J Laarman, Gerdien Mijnheer, Joe M Mootz, et al.
Cell Communication and Signaling : CCS|March 13, 2026
Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradationGuancong Luo, Dexuan Li, Jun Peng, et al.
CJC Open|November 11, 2024
Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid GuidelineG B John Mancini, Glen J Pearson, Arden R Barry, et al.
The Canadian Journal of Cardiology|October 8, 2016
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultTodd J Anderson, Jean Grégoire, Glen J Pearson, et al.
The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
The Canadian Journal of Cardiology|March 5, 2014
Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia PanelTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
Pageof 16